MINERVA SURGICAL INC: Nasdaq/NYSE listing notice — Minerva Surgical receives Nasdaq deficiency notice for bid price below $1.00

MINERVA SURGICAL INC

Closing bid price below $1.00 for 30 consecutive business days triggers Nasdaq notice.
Company has 180 calendar days, until May 1, 2023, to regain compliance.
To regain compliance, bid price must close at $1.00+ for 10 consecutive business days.
If not cured, may seek a second 180-day period if other listing standards are met.
Intends to consider a reverse stock split to cure the deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 1.0

MINERVA SURGICAL INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

October 31, 2022, Minerva Surgical, Inc. (the “Company”) received a notification from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that for the last 30 consecutive business days, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Global Select Market pursuant to Listing Rule 5450(a)(1). This notice has no immediate effect on the Company’s Nasdaq listing or trading of its common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-22-021215

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.